Access routes and asking prices: Getting drugs to cancer patients
What’s a fair price for a drug? How can we make sure more patients have access to the latest treatments?
Read more
BICRA gene provides answers to patients, doctors and scientists
Physicians and scientists are constantly on the lookout for new disease genes that can help them understand why patients have
Read more
Emergency imaging trends in pediatric vs. adult patients for abdominal pain
According to an article in ARRS’ American Journal of Roentgenology (AJR), although pediatric CT use has decreased for the evaluation
Read more
As a trans counsellor, I see the pain my patients go through just to be believed
The 16-year-old trans girl in front of me was in tears. As a gender specialist counsellor, she had come to
Read more
Algorithm-driven digital program helped lower patients’ cholesterol, blood pressure
Using a remotely-delivered, algorithm-driven program for disease management, patients experienced significant improvement in cholesterol and blood pressure levels, according to
Read more
Study identifies patients with lung cancer most likely to respond to immunotherapy
Scientists are beginning to unravel one of the biggest challenges with immunotherapy: why some people with cancer respond to the
Read more
Combining population health management and online program may help patients lose weight
Over 70 percent of U.S. adults have overweight or obesity. While primary care physicians (PCPs) are often the most immediate
Read more
FDA Approves Merck’s Keytruda (pembrolizumab) in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple‑Negative Breast Cancer Whose Tumors Express PD-L1 (CPS ≥10)
KENILWORTH, N.J.–(BUSINESS WIRE) November 13, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today
Read more
Hydroxychloroquine not linked to longer heart rhythm intervals in RA or lupus patients
New research presented at ACR Convergence, the American College of Rheumatology’s annual meeting, discovers that use of hydroxychloroquine, a generic
Read more
Update on CALAVI Phase II Trials for Calquence in Patients Hospitalised with Respiratory Symptoms of COVID-19
12 November 2020 — The CALAVI Phase II trials for Calquence (acalabrutinib) in patients hospitalised with respiratory symptoms of COVID-19 did not
Read more